Literature DB >> 8294083

Dopaminergic modulation of visual sensitivity in man.

G Masson1, D Mestre, O Blin.   

Abstract

A large body of experimental evidence supports the hypothesis that dopamine is a functional neuromodulator at many levels of the visual system. Intrinsic dopaminergic neurons were characterized in most mammalian retina, including man. These neurons give rise to a dendritic plexus covering the retina. Thus, dopamine seems to be involved in the organization of the ganglion cell and the bipolar cell receptive fields and modulates physiological activity of photoreceptors, both processes which underlie sensitivity and spatial selectivity of visual processing in the early stage of the visual system. Moreover, few data are now available concerning the functional significance of dopaminergic modulation of visual sensitivity in man. Parkinson's disease is a specific disorder of central dopaminergic systems. Abnormalities in the pattern-evoked potentials and electroretinogram have been found in parkinsonian patients. Contrast sensitivity, a useful tool for measuring visual spatio-temporal sensitivity in man, has also been shown to be modified due to this affection. Dynamic contrast sensitivity is primarily decreased in these patients, distinguishing them from the normal aging process. Because these modifications in shape of the contrast sensitivity function are reversed by L-Dopa, and that neuroleptic administration could reproduce them in schizophrenia patients, it was suggested that dopamine might tune the contrast sensitivity function in man. We have recently shown that subcutaneous apomorphine induces changes in contrast sensitivity in healthy volunteers, which preferentially affect motion sensitivity. These dopaminergic sensitive modifications in the shape of the contrast sensitivity function might reflect a change in the range of sensitivity of the visual system, both in dynamic and spatial properties. This could be explained by a modification in the spatial and dynamic properties of the ganglion cell responses in the retina. Moreover, we suggest both from our results and from the review of the literature that human psychophysical data confirm the hypothesis that dopamine may be involved in light retinal adaptation, as light-induced and dopamine-induced modifications in the shape in the contrast sensitivity function are quite similar.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8294083     DOI: 10.1111/j.1472-8206.1993.tb01041.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  21 in total

1.  Effects of dopamine depletion on visual sensitivity of zebrafish.

Authors:  L Li; J E Dowling
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

2.  Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson's disease.

Authors:  Mohammad Rohani; Arash Sefidkar Langroodi; Shadi Ghourchian; Khalil Ghasemi Falavarjani; Reza SoUdi; Gholamali Shahidi
Journal:  Neurol Sci       Date:  2012-06-03       Impact factor: 3.307

3.  Effects of dopamine D-1 and D-2 receptors on intraocular pressure in conscious rabbits.

Authors:  C Prünte; I Nuttli; R Markstein; C Kohler
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Contrast sensitivity and motion discrimination in cannabis users.

Authors:  Elena Mikulskaya; Frances Heritage Martin
Journal:  Psychopharmacology (Berl)       Date:  2018-06-16       Impact factor: 4.530

5.  Oral levodopa rescues retinal morphology and visual function in a murine model of human albinism.

Authors:  Helena Lee; Jennifer Scott; Helen Griffiths; Jay E Self; Andrew Lotery
Journal:  Pigment Cell Melanoma Res       Date:  2019-04-02       Impact factor: 4.693

6.  Deficient visual sensitivity in schizotypal personality disorder.

Authors:  Brendon W Kent; Zachary A Weinstein; Vincent Passarelli; Yue Chen; Larry J Siever
Journal:  Schizophr Res       Date:  2010-06-11       Impact factor: 4.939

Review 7.  The retina as a window to the brain-from eye research to CNS disorders.

Authors:  Anat London; Inbal Benhar; Michal Schwartz
Journal:  Nat Rev Neurol       Date:  2012-11-20       Impact factor: 42.937

8.  [Loss of visual acuity after treatment with pipamperone].

Authors:  D Loos; P Kook; J Huber; C Zorn; C P Lohmann; D Zapp; M Maier
Journal:  Ophthalmologe       Date:  2011-08       Impact factor: 1.059

9.  Retinal dopamine mediates multiple dimensions of light-adapted vision.

Authors:  Chad R Jackson; Guo-Xiang Ruan; Fazila Aseem; Jane Abey; Karen Gamble; Greg Stanwood; Richard D Palmiter; P Michael Iuvone; Douglas G McMahon
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

Review 10.  Retinopathy in Parkinson Disease.

Authors:  Ivan Bodis-Wollner
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.